Trevi Therapeutics (TRVI) Narrows Q3 Loss to $11.8M as Haduvio Advances Toward Major Milestone
Trevi Therapeutics, Inc. (NASDAQ:TRVI) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…